Company intelligence / Profile preview

AbMole BioScience

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

AbMole BioScience is an active commercial supplier of high-purity inhibitors and research reagents for laboratory use; its products are widely used in research settings including signaling pathway studies on targets such as HDAC, PI3K, and apoptosis. The company is not a drug developer and does not conduct clinical trials; its outputs are strictly for research use and not intended for human administration.

Modalities: Small moleculePeptidesRecombinant proteinAntibody
Industry: Chemicals & Materials

Beyond the preview

Go deeper on AbMole BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AbMole BioScience.

Explore the full profile